本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Redhill Biopharma Ltd

0.7845
-0.0285-3.51%
盤後0.79570.0112+1.43%19:53 EDT
成交量:1.28萬
成交額:1.04萬
市值:399.49萬
市盈率:-0.13
高:0.8544
開:0.8365
低:0.7835
收:0.8130
52周最高:3.31
52周最低:0.7101
股本:509.23萬
流通股本:332.99萬
量比:0.52
換手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-6.0249
每股收益(LYR):-6.7096
淨資產收益率:-1708.61%
總資產收益率:-25.32%
市淨率:-0.91
市盈率(LYR):-0.12

資料載入中...

2020/02/25

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]